PipeBio is a cloud-based bioinformatics platform designed to streamline the discovery and development of biologics, including antibodies, T-cell receptors (TCRs), and peptides. It offers scientists and bioinformaticians a comprehensive suite of tools for analyzing, visualizing, and managing large-scale sequence data, facilitating faster and more efficient research processes.
Key Features and Functionality:
- Sequence Analysis: Supports the analysis of B-cell receptors (BCR), TCRs, single-chain variable fragments (scFv), variable heavy domains (VHH), and peptides, enabling detailed examination and annotation of sequences.
- Automated Workflows: Allows users to configure and execute end-to-end workflows, automating the identification of candidate sequences from extensive next-generation sequencing (NGS) antibody repertoires, hybridoma sequencing, and biopanning experiments.
- Sequence Database and Storage: Provides a centralized database to store antibody sequences, associate relevant metadata such as target specificity and binding affinity, and compare new experimental sequences with existing data.
- Integration and API: Offers integration capabilities with electronic lab notebooks (ELN), laboratory information management systems (LIMS), and internal tools through a REST API, facilitating seamless data exchange and workflow automation.
- Visualization Tools: Includes interactive charts and plots to visualize sequence clusters, amino acid frequencies, codon usage, sequence quality, and phylogenetic relationships, enhancing data interpretation.
- Antibody Engineering: Features tools for editing sequences at the nucleotide or protein level, calculating protein properties, optimizing codons for synthesis, and analyzing hydrophobicity, supporting the engineering of improved antibody candidates.
Primary Value and Problem Solved:
PipeBio addresses the challenges associated with managing and analyzing large-scale sequence data in biologics research. By providing an integrated, user-friendly platform, it enables researchers to efficiently process and interpret complex datasets, identify promising candidates, and accelerate the development of therapeutic biologics. The platform's automation and integration capabilities reduce manual tasks, minimize errors, and enhance collaboration, ultimately leading to faster and more effective drug discovery processes.
